menu
    • menu

    Company profile for Basilea Pharmaceutica

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Basilea is a revenue-generating, commercial-stage Swiss biotech company. Our activities are focused in the areas of oncology, hospital antibiotics and hospital antifungals. Our portfolio comprises of two marketed anti-infective brands (Cresemba® and Zevtera®) and three oncology drug candidates in development. We are building on our potential for sustainable growth and valuation generation, based on increasing revenues and se...
    Basilea is a revenue-generating, commercial-stage Swiss biotech company. Our activities are focused in the areas of oncology, hospital antibiotics and hospital antifungals. Our portfolio comprises of two marketed anti-infective brands (Cresemba® and Zevtera®) and three oncology drug candidates in development. We are building on our potential for sustainable growth and valuation generation, based on increasing revenues and selective investments into internal and external innovation. Basilea was founded in 2000 as a spin-out from Roche and is headquartered in the heart of the life sciences hub of Basel.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Basilea PharmaceuticaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Grenzacherstrasse 487 PO Box 4005 Basel
    Telephone
    Telephone
    +41 61 606 11 11
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.basilea.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/basilea-pharmaceutica-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam
    Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3155972/0/en/Basilea-awarded-BARDA-contract-for-the-development-of-novel-oral-phase-3-ready-antibiotic-ceftibuten-ledaborbactam.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Basilea secures $25M BARDA funding for antifungals Fosmanogepix
    Basilea secures $25M BARDA funding for antifungals Fosmanogepix

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150497/0/en/Basilea-receives-USD-25-million-funding-under-BARDA-agreement-to-continue-to-advance-novel-antifungals-fosmanogepix-and-BAL2062.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Basilea Reports Strong Half-Year Results for 2025
    Basilea Reports Strong Half-Year Results for 2025

    19 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/19/3135398/0/en/Basilea-on-track-with-strong-2025-half-year-results.html

    GLOBENEWSWIRE
    19 Aug 2025
    Share Share
    Basilea In-Licenses Novel Oral Antibiotic for Clinical Phase 3
    Basilea In-Licenses Novel Oral Antibiotic for Clinical Phase 3

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133159/0/en/Basilea-announces-in-licensing-of-a-novel-clinical-phase-3-ready-oral-antibiotic.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Basilea Starts Phase 3 Fosmanogepix Study for Mold Infections
    Basilea Starts Phase 3 Fosmanogepix Study for Mold Infections

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3122965/0/en/Basilea-initiates-phase-3-study-with-antifungal-fosmanogepix-in-invasive-mold-infections.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share
    Basilea gets USD 39M BARDA funding for antifungals fosmanogepix
    Basilea gets USD 39M BARDA funding for antifungals fosmanogepix

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111437/0/en/Basilea-receives-USD-39-million-funding-under-BARDA-agreement-to-continue-to-advance-novel-antifungals-fosmanogepix-and-BAL2062.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search